Beacon Pointe Advisors, LLC Bausch Health Companies Inc. Transaction History

Beacon Pointe Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$7.06 - $23.63 $6,827 - $22,850	967 Added 8.84%	11,900 $99,000
Q1 2022 May 17, 2022	BUY	$21.6 - $27.79 $17,366 - $22,343	804 Added 7.94%	10,933 $250,000
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $111,453 - $133,797	-4,451 Reduced 30.53%	10,129 $282,000
Q2 2021 Aug 17, 2021	BUY	$27.43 - $32.7 $84,347 - $100,552	3,075 Added 26.73%	14,580 $427,000
Q1 2021 May 18, 2021	SELL	$21.37 - $34.38 $134,631 - $216,594	-6,300 Reduced 35.38%	11,505 $366,000
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $37,203 - $51,321	-2,430 Reduced 12.01%	17,805 $368,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $269,327 - $415,019	20,235 New	20,235 $370,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.